Simplify Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$641K Buy
15,014
+3,690
+33% +$200K 0.01% 99
2026
Q1
$711K Sell
11,324
-4,227
-27% -$338K 0.01% 91
2025
Q4
$1.48M Buy
15,551
+7,464
+92% +$732K 0.02% 75
2025
Q3
$790K Buy
8,087
+984
+14% +$102K 0.01% 87
2025
Q2
$763K Buy
+7,103
New +$719K 0.04% 66
2024
Q3
Sell
-79,639
Closed -$6.13M 108
2024
Q2
$6.13M Buy
79,639
+17,181
+28% +$1.26M 0.41% 25
2024
Q1
$4.28M Buy
62,458
+33,370
+115% +$2.15M 0.25% 32
2023
Q4
$1.68M Sell
29,088
-32,028
-52% -$1.71M 0.15% 53
2023
Q3
$3.23M Buy
61,116
+49,304
+417% +$2.59M 0.37% 30
2023
Q2
$639K Buy
11,812
+2,926
+33% +$153K 0.08% 87
2023
Q1
$445K Sell
8,886
-2,660
-23% -$125K 0.06% 87
2022
Q4
$534K Buy
11,546
+931
+9% +$40.3K 0.08% 50
2022
Q3
$411K Buy
10,615
+3,325
+46% +$133K 0.04% 55
2022
Q2
$272K Sell
7,290
-11,992
-62% -$488K 0.01% 62
2022
Q1
$854K Buy
19,282
+12,792
+197% +$554K 0.03% 44
2021
Q4
$276K Buy
+6,490
New +$273K 0.01% 63

Other funds holding BSX

Simplify Asset Management's BSX Position: Q2 2026 in Review

Simplify Asset Management increased its Boston Scientific (BSX) stake by 33% in Q2 2026, buying an estimated $200K and bringing the position to 15,014 shares worth $641K. The position accounts for 0.01% of the portfolio, ranked #99.

Simplify Asset Management first reported a position in BSX in Q4 2021 and has held it in 16 quarters since. The position peaked at $6.13M in Q2 2024. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Simplify Asset Management held 15,014 shares of Boston Scientific worth $641K as of Q2 2026.
  • Simplify Asset Management bought 3,690 Boston Scientific shares in Q2 2026, an estimated $200K.
  • Boston Scientific made up 0.01% of Simplify Asset Management's portfolio in Q2 2026, its #99 holding.
  • Simplify Asset Management first reported a position in Boston Scientific in Q4 2021 and has held it in 16 quarters since.
  • Simplify Asset Management's Boston Scientific position peaked at $6.13M in Q2 2024.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.